TLDR
- Lam Research delivered fiscal Q3 earnings per share of $1.47, surpassing the $1.36 consensus, while revenue reached $5.84 billion — representing a 24% year-over-year increase.
- Fourth-quarter projections significantly exceeded Wall Street expectations for both revenue and profit.
- Gross profit margins expanded approximately 100 basis points to 50.5%, supported by favorable product mix and operational improvements.
- BofA Securities increased its price target to $330 from $285, reaffirming a Buy rating, while boosting its 2027 EPS forecast by 33%.
- Shares have skyrocketed more than 300% over the past year and are now trading close to the 52-week peak of $273.50.
Lam Research delivered a comprehensive earnings beat for its fiscal third quarter, propelling shares upward during Thursday’s premarket session. The semiconductor equipment manufacturer posted earnings per share of $1.47 compared to the Street’s $1.36 forecast, while revenue hit $5.84 billion against projections of $5.75 billion — marking a robust 24% year-over-year climb.
Lam Research Corporation, LRCX
The company’s fourth-quarter outlook stole the spotlight. Management’s projections for both top-line and bottom-line performance exceeded analyst estimates by approximately 9% and 14%, respectively. This combination of strong results and raised guidance proved exactly what investors were hoping to see.
CEO Tim Archer emphasized during the quarterly conference call why Lam Research is uniquely positioned for success. “For Lam, the AI driven demand environment is creating an ideal setup for continued outperformance,” he explained. Looking further ahead, he expressed confidence about 2027, stating “it feels like it’s setting up to be a pretty good year.”
Margins and Analyst Reaction
The company’s gross profit margin reached 50.5%, expanding by roughly 100 basis points thanks to improved product mix optimization and enhanced operational efficiency. This profitability enhancement drew attention from BofA Securities analyst Vivek Arya, who elevated the firm’s price target to $330 from the previous $285 while maintaining a Buy recommendation.
BofA Securities also revised upward its calendar year 2026 earnings estimate by 12% to $9.21 per share and its 2027 projection by an impressive 33% to $10.31. The updated $330 price target reflects a 36x multiple on the firm’s 2027 earnings estimate. Arya highlighted that Lam’s customer base is already engaging in strategic planning discussions for calendar year 2028 with strong conviction — suggesting the current growth cycle has significant staying power.
The investment bank simultaneously raised its 2026 wafer fabrication equipment market forecast to $140 billion from $135 billion, projecting Lam to outpace overall industry expansion through its strong positioning in etch and deposition technologies and ongoing market share capture.
What’s Driving Demand
Lam Research specializes in manufacturing equipment for the etching phase of semiconductor fabrication — the critical process that precisely patterns microscopic transistors onto silicon wafers. The company’s primary rivals in this segment include Applied Materials and Tokyo Electron.
Traditionally, the company’s performance correlated strongly with consumer electronics demand cycles. That narrative has fundamentally shifted. Beginning in late 2023, artificial intelligence infrastructure expansion has emerged as the primary growth catalyst, generating consistent equipment orders from major customers including TSMC and Micron, both of which are ramping up capital expenditures throughout this year and extending into 2026.
Should current Street forecasts prove accurate, Lam Research is positioned to achieve its third straight quarter of all-time high revenue.
Shares advanced 1.3% in Thursday’s premarket trading session and currently hover near the 52-week peak of $273.50, with the stock changing hands at $265.55. The consensus analyst price target stands at $286, though BofA Securities’ newly established $330 target represents considerable upside from that level. The equity currently trades at a price-to-earnings multiple of 54.32 times trailing earnings.
